Mode
Text Size
Log in / Sign up
N/A N=327 Randomized Supportive Care

Improving Follow-Up for Discharged Emergency Care Patients

General Medicine · Emergency Medicine · Mobile Health

Enrolled (actual)
327
Serious AEs
11.5%
Results posted
Nov 2020
Primary outcome: Primary: Adherence to Follow-up Appointment — 30; 74 Participants — p=<0.001

Study Design & Population

Study type
Interventional
Phase
N/A
Interventions
Epharmix/CareSignal eHealth (Device)
Age
Pediatric, Adult, Older Adult · 5+ yrs
Sex
All
Sponsor
Washington University School of Medicine
Primary completion
Sep 2017

Outcome Measures

OutcomeResultp-value
PRIMARY
Adherence to Follow-up Appointment
30; 74 <0.001 sig
SECONDARY
Revisits to the ED
50; 60 0.8

Summary

This study's purpose is to test the effects of an electronic health intervention platform developed by Epharmix (also known as CareSignal), which features two-way SMS text messages and phone calls intended to improve clinical outcomes compared to the standard of care. This was a randomized open, blinded end-point (PROBE) trial of adult patients discharged from the ED and referred to a provider for follow-up care. Participants in the intervention arm received a self-scheduling text or phone message that automatically connected them to their referral provider to schedule a follow-up appointment and sent them appointment reminders. Those in the control arm received standard of care written instructions to contact listed referral providers. The primary outcome was time to the follow-up appointment.

Eligibility Criteria

Inclusion Criteria

  • age 18 years or older,
  • accessible short message service (SMS) capable mobile phone or residential landline,
  • able to read English or have English-speaking family member to assist with phone communications,
  • discharged directly from the Barnes Jewish hospital (St. Louis, MO) emergency department (ED), and
  • given a clinical referral to make an outpatient follow-up appointment at time of discharge to a specific clinic or provider

Exclusion Criteria

  • unable or refused to provide consent,
  • could not be contacted by a phone call or SMS,
  • non-English speaking,
  • were admitted to the hospital, and
  • already had a follow-up appointment scheduled before being discharged from the ED
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03002311). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.

Back to search